Cancer tumours that contain higher levels of Vitamin C are less aggressive and slower to grow than ones with lower levels of the vitamin.
That’s according to ground-breaking research already done by Professor Margreet Vissers and her team at the University of Otago, Christchurch.
They found that vitamin C controls crucial proteins involved in tumour growth and survival, and potentially limits cancer growth through a number of mechanisms, including the formation of new blood vessels that allow the tumour to thrive.
Her work was recently featured on TVNZ’s Sunday programme.
The next step: human clinical trials
Vitamin C has been proposed to be of benefit to cancer patients, and could potentially be used effectively alongside existing therapies.
However, the anti-cancer potential of vitamin C cannot be determined without proper scientific evidence for its mechanism of action and controlled clinical studies.
Professor Vissers estimates these studies will cost $1 million.
Make it happen: donate to our Vitamin C for Cancer Trust
Professor Vissers and her team from the Centre for Free Radical Research and the University of Otago, Christchurch are raising $1 million to carry out these clinical studies.
They will investigate the anti-cancer mechanism of vitamin C and determine the best clinical conditions for its potential use.